Optimizing treatment for men with advanced prostate cancer: Expert recommendations and the multidisciplinary approach-Reference-Cited by-同舟云学术

Optimizing treatment for men with advanced prostate cancer: Expert recommendations and the multidisciplinary approach

Published:2008-10 Issue:1 Volume:68 Page:S9-S22
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Fitzpatrick John M.,Anderson John,Sternberg Cora N.,Fleshner Neil,Fizazi Karim,Rébillard Xavier,Dogliotti Luigi,Conti Giario,Turesson Ingela,James Nicholas,Heidenreich Axel,Solsona Eduardo,Guillem Vicente,Herchenhorn Daniel,Moul Judd,van Moorselaar Jeroen,Coetzee Lance J.E.,Wilson Andrew,Bamias Aristotelis,De Wit Ronald,Chrisofos Michael

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference42 articles.

1. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

2. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

3. Advanced prostate cancer: at last a role for medical oncologists;Dogliotti;Eur Urol,2007

4. Cancer facts & figures 2007;American Cancer Society,2007

5. Treatments for prostate cancer in older men: 1984–1997;Bubolz;Urology,2001

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3;Theranostics;2021

2. Specialist visits and initiation of cancer-directed treatment among a large cohort of men diagnosed with prostate cancer;Urologic Oncology: Seminars and Original Investigations;2017-04

3. Multidisciplinary Approach of Prostate Cancer Patients;Bone Metastases from Prostate Cancer;2016-11-08

4. Prostate Cancer Unit Initiative in Europe: A position paper by the European School of Oncology;Critical Reviews in Oncology/Hematology;2015-08

5. Safety and antitumor efficacy of 153Sm-EDTMP and docetaxel administered sequentially to patients with metastatic castration-resistant prostate cancer;Nuclear Medicine Communications;2014-01